Microneedles permit transdermal delivery of a skin-impermeant medication to humans
暂无分享,去创建一个
Mark R Prausnitz | Jyoti Gupta | Harvinder S Gill | M. Prausnitz | H. Gill | D. Wermeling | A. Stinchcomb | S. Banks | David A Hudson | Jyoti Gupta | Audra L Stinchcomb | Daniel P Wermeling | Stan L Banks
[1] S. Mitragotri,et al. Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[2] M. Wall,et al. Metabolism and disposition of naltrexone in man after oral and intravenous administration. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[3] A. Stinchcomb,et al. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] M. Roberts,et al. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? , 2004, Current drug delivery.
[5] Mark R Prausnitz,et al. Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[6] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[7] Adrian C. Williams,et al. Penetration enhancers. , 2004, Advanced drug delivery reviews.
[8] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[9] T. Hampton. Breaking barriers in transdermal drug delivery. , 2005, JAMA.
[10] Michael L. Reed,et al. Microsystems for drug and gene delivery , 2004, Proceedings of the IEEE.
[11] Wijaya Martanto,et al. Mechanism of fluid infusion during microneedle insertion and retraction. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[12] M. Wall,et al. Naltrexone disposition in man after subcutaneous administration. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[13] B. Silverman,et al. Pharmacokinetics of Long‐Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment , 2005, Journal of clinical pharmacology.
[14] W. Miller,et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. , 2008, Journal of studies on alcohol and drugs.
[15] Mark R Prausnitz,et al. Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.
[16] Regina Luttge,et al. Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .
[17] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] David Couper,et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.
[19] S. Mitragotri,et al. Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.
[20] J. Volpicelli,et al. Naltrexone biotransformation and incidence of subjective side effects: a preliminary study. , 1997, Alcoholism: Clinical and Experimental Research.
[21] J. Yoshimitsu,et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.
[22] Richard A.F. Clark,et al. The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.
[23] J. Volavka,et al. Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing , 1976, Clinical pharmacology and therapeutics.
[24] P. Crooks,et al. Human Skin Permeation of Branched-Chain 3-O-Alkyl Ester and Carbonate Prodrugs of Naltrexone , 2005, Pharmaceutical Research.
[25] S. Mitragotri,et al. Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[26] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[27] P. Crooks,et al. Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[28] Dorian Liepmann,et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.